{"Allocation":"Randomized","CompleteTime":53,"DesignModel":"Crossover Assignment","DrugInformation":{"ArmGroupList":[{"ArmGroupDescription":"eplerenone 50mg/day (cross over design): 50 mg/day 6-month , ","ArmGroupLabel":"Eplerenone group A (cross over design)","ArmGroupType":"Active Comparator","InterventionDescription":[{"Dosage":"50mg / day","DrugName":"eplerenone 50mg/day (cross ove  design)","Duration":"6-month","HowToTake":"","OtherName":[]}],"InterventionList":{"ArmGroupInterventionName":["drug: eplerenone 50mg/day (cross over design)","drug: other: period without eplerenone (cross over design)"]}},{"ArmGroupDescription":"eplerenone 50mg/day (cross over design): 50 mg/day 6-month , ","ArmGroupLabel":"Eplerenone group B (cross over design)","ArmGroupType":"Active Comparator","InterventionDescription":[{"Dosage":"single dose","DrugName":"eplerenone 50mg/day (cross ove  design)","Duration":"6-month","HowToTake":"","OtherName":[]}],"InterventionList":{"ArmGroupInterventionName":["drug: eplerenone 50mg/day (cross over design)","drug: other: period without eplerenone (cross over design)"]}}]},"Enrollment":"36","InterventionName":"eplerenone, Period without eplerenone (cross over design)","Masking":"None (Open Label)","NCTID":"NCT04450953","Objective":"The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.","OfficialTitle":"A Randomized Crossover Clinical Trial Regarding the Blockage of the Mineralocorticoid Receptor Using Eplerenone on the Evolution of Arterial Stiffness in Kidney Patients One Year After Transplant","PopulationBox":{"Condition":"lack;'>Condition: lack;'>Condition: lack;'>Condition: Kidney Transplantation for More Than One YearPatients With a Kidney Transplantation on Cyclosporine</a></a></a>","Gender":"lack;'>Gender: lack;'>Gender: lack;'>Gender: All</a></a></a>","HealthyCondition":"lack;'>Healthy condition: lack;'>Healthy condition: lack;'>Healthy condition: No</a></a></a>","MaxAge":"","MinAge":"lack;'>Min age: lack;'>Min age: lack;'>Min age: 50 Years</a></a></a>","Participant":"36"},"PopulationRatio":"<a href='#armgroup' target='_self' style='color:black;'><a href='#armgroup' target='_self' style='color:black;'><a href='#armgroup' target='_self' style='color:black;'></a></a></a>","Title":"The Effect of Eplerenone on the Evolution of Vasculopathy in Renal Transplant Patients.","WashoutPeriod":"10 weeks","_id":"NCT04450953","version":"1.7.1"}